LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	14.23	22.98	14.98	21.4
Short-Term Investments	-	5.02	28.31	-
Cash & Short-Term Investments	14.23	28	43.29	21.4
Cash Growth	-67.14%	-35.32%	102.26%	-
Prepaid Expenses	0.56	0.88	2.34	0.08
Other Current Assets	-	-	0.01	0.01
Total Current Assets	14.78	28.88	45.63	21.49
Property, Plant & Equipment	3.96	4.16	0.02	0
Other Long-Term Assets	0.51	0.5	-	-
Total Assets	19.25	33.53	45.66	21.49
Accounts Payable	0.64	2.32	1.39	0.16
Accrued Expenses	2.54	5.3	1.22	0.31
Current Portion of Leases	0.73	0.49	-	-
Total Current Liabilities	3.91	8.11	2.61	0.47
Long-Term Debt	-	-	-	24.15
Long-Term Leases	3.03	3.22	-	-
Other Long-Term Liabilities	1.93	2.5	1.56	18.49
Total Liabilities	8.86	13.83	4.16	43.11
Common Stock	0	0	0	0
Additional Paid-In Capital	10.63	9.66	6.47	6.13
Retained Earnings	-114.5	-104.32	-41.22	-34.95
Comprehensive Income & Other	-	0.11	0.27	-
Total Common Equity	-103.87	-94.55	-34.47	-28.81
Shareholders' Equity	10.39	19.71	41.49	-21.62
Total Liabilities & Equity	19.25	33.53	45.66	21.49
Total Debt	3.76	3.7	-	24.15
Net Cash (Debt)	10.46	24.3	43.29	-2.74
Net Cash Growth	-75.83%	-43.88%	-	-
Net Cash Per Share	41.56	96.49	173.44	-11.87
Filing Date Shares Outstanding	0.25	0.25	0.25	0.23
Total Common Shares Outstanding	0.25	0.25	0.25	0.23
Working Capital	10.88	20.77	43.03	21.02
Book Value Per Share	-412.54	-375.53	-138.11	-124.68
Tangible Book Value	-103.87	-94.55	-34.47	-28.81
Tangible Book Value Per Share	-412.54	-375.53	-138.11	-124.68
Machinery	0.48	0.47	0.03	0.01
Leasehold Improvements	1.49	1.49	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q